These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20541686)

  • 21. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
    Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
    Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy and melanoma: 2010 update Part I.
    Stebbins WG; Garibyan L; Sober AJ
    J Am Acad Dermatol; 2010 May; 62(5):723-34; quiz 735-6. PubMed ID: 20398810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma.
    de Vries M; Speijers MJ; Bastiaannet E; Plukker JT; Brouwers AH; van Ginkel RJ; Suurmeijer AJ; Hoekstra HJ
    Eur J Surg Oncol; 2011 Aug; 37(8):681-7. PubMed ID: 21636244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in sentinel node staging in melanoma: controversies and alternatives.
    van Akkooi AC; Voit CA; Verhoef C; Eggermont AM
    Curr Opin Oncol; 2010 May; 22(3):169-77. PubMed ID: 20168231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy for melanoma is still controversial.
    Garcia C; Poletti E
    J Am Acad Dermatol; 2007 Feb; 56(2):347-8. PubMed ID: 17224378
    [No Abstract]   [Full Text] [Related]  

  • 33. Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma.
    Thomas JM
    J Am Acad Dermatol; 2009 Dec; 61(6):1079. PubMed ID: 19925932
    [No Abstract]   [Full Text] [Related]  

  • 34. [For the benefit of the patient: the sentinel node excision].
    Satzger I; Klein M; Löser C; Möhrle M; Reske S; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):922-6. PubMed ID: 22026360
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience.
    Topping A; Dewar D; Rose V; Cavale N; Allen R; Cook M; Powell B
    Br J Plast Surg; 2004 Mar; 57(2):97-104. PubMed ID: 15037163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.
    Thomas JM
    J Clin Oncol; 2005 Dec; 23(36):9443-4. PubMed ID: 16361650
    [No Abstract]   [Full Text] [Related]  

  • 40. The significance of melanoma micrometastases in the sentinel lymph node.
    Giblin AV; Hayes AJ; Thomas JM
    Eur J Surg Oncol; 2005 Dec; 31(10):1103-4. PubMed ID: 16084052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.